Page 3 - J&j

Delhi HC sets ball rolling on J&J's faulty hip implant damages

Firm willing to pay RS 25 lakh only to 'revision surgery' patients, not others

J&J loses motion to overturn $4.7 billion talc-ovarian cancer verdict

(Reuters) - Healthcare conglomerate Johnson & Johnson has lost its motion to reverse a verdict that awarded $4.7 billion to women who blamed ovarian cancer on asbestos in the company's Baby Powder and other talc products, a Missouri court ruled on Wednesday.

J&J scandal is India's wake-up call to reform rules for medical devices

The absence of compensation provisions in the Drugs & Cosmetics Act puts the spotlight on the gaps in the regulatory regime

J&J powders tested positive for asbestos from 1971 to the early 2000s

Company executives, mine managers, scientists, doctors and lawyers fretted over the problem and how to address it while failing to disclose it to regulators or the public

Faulty hip implants case: J&J agrees to pay compensation, says govt

The government wrote to J&J's subsidiary DePuy Medical, which made the devices, asking them to provide compensation till 2025

J&J's largest India plant to be operational by 2018

J&J's India bet comes at a time when it has faced consumer ire in the US